After filling its pipeline with Big Pharma-partnered antibody therapeutics, J&J darling Genmab has turned to a fellow European biotech for its latest foray into cancer immunotherapies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,